Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: Retrospective cohort study and literature review
David Hettle, Stephanie Hutchings, Peter Muir, et al.
Clinical Infection in Practice (2022) Vol. 16, pp. 100210-100210
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies
Danilo Buonsenso, Laura Martino, Rosa Morello, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 9, pp. e745-e756
Open Access | Times Cited: 32
Early combination therapy of COVID-19 in high-risk patients
Hans Martin Orth, Charlotte Flasshove, Moritz Berger, et al.
Infection (2023) Vol. 52, Iss. 3, pp. 877-889
Open Access | Times Cited: 26
Role of Spillover and Spillback in SARS-CoV-2 Transmission and the Importance of One Health in Understanding the Dynamics of the COVID-19 Pandemic
McKenzie N. Sparrer, Natasha F. Hodges, Tyler Sherman, et al.
Journal of Clinical Microbiology (2023) Vol. 61, Iss. 7
Open Access | Times Cited: 25
Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis
Dominique Fournelle, Fatima Mostefai, Elsa Brunet‐Ratnasingham, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 342-342
Open Access | Times Cited: 9
Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report
Bénédicte Billi, Paul Cholley, Vincent Grobost, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series
Bianca Maria Longo, Francesco Venuti, Alberto Gaviraghi, et al.
Antibiotics (2023) Vol. 12, Iss. 9, pp. 1460-1460
Open Access | Times Cited: 12
CD4 + and CD8 + T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment
Meenakshi Kar, Katherine Johnson, Abigail Vanderheiden, et al.
Science Advances (2024) Vol. 10, Iss. 34
Open Access | Times Cited: 4
Efficacy of antiviral therapy and disease outcomes in COVID-19 patients previously treated with obinutuzumab for follicular lymphoma
Nobuhiro Okagaki, Seishu Hashimoto, Satoshi N. Nakamura, et al.
Tenri Medical Bulletin (2025)
Open Access
Evolutionary Mechanisms of the Emergence of the Variants of Concern of SARS-CoV-2
Igor M. Rouzine
Viruses (2025) Vol. 17, Iss. 2, pp. 197-197
Open Access
Prolonged COVID-19 Pneumonia in Patients with Hematologic Malignancies: Clinical Significance and Serial CT Findings
Dae Hee Han, Raeseok Lee, Gi June Min, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 8, pp. 2701-2701
Open Access
In-depth analysis of the risk factors for persistent severe acute respiratory syndrome coronavirus 2 infection and construction of predictive models: an exploratory research study
Jia Zhang, Weihua Zhu, Piping Jiang, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis
Zoe Raglow, Diya Surie, James D. Chappell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review
Paul Kinsella, Michael A. Moso, C. Orla Morrissey, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Open Access | Times Cited: 3
CD4+ and CD8+ T cells are required to prevent SARS-CoV-2 persistence in the nasal compartment
Meenakshi Kar, Katherine Johnson, Abigail Vanderheiden, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Longitudinal analysis of genomic mutations in SARS-CoV-2 isolates from persistent COVID-19 patient
Hiroki Futatsusako, Rina Hashimoto, Masaki Yamamoto, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109597-109597
Open Access | Times Cited: 2
Radiologic Abnormalities in Prolonged SARS-CoV-2 Infection: A Systematic Review
Kyongmin Sarah Beck, Jeong‐Hwa Yoon, Soon Ho Yoon
Korean Journal of Radiology (2024) Vol. 25, Iss. 5, pp. 473-473
Open Access | Times Cited: 2
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients
Chiara Sepulcri, Claudia Bartalucci, Małgorzata Mikulska
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 506-517
Closed Access | Times Cited: 2
Phylogenetic meta-analysis of chronic SARS-CoV-2 infections in immunocompromised patients shows no evidence of elevated evolutionary rates
Sanni Översti, Emily Gaul, Björn‐Erik Ole Jensen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Management of SARS-CoV-2 and Persistent Viral Detection in Solid Organ Transplant Recipients
Karen Larissa Pereira de Castro, Chetan Naik, Cedric W. Spak, et al.
Current Pulmonology Reports (2024) Vol. 13, Iss. 1, pp. 26-37
Open Access | Times Cited: 1
Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylation
Savanna S. Skeeters, Kamal Bagale, Galina A. Stepanyuk, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 3, pp. 101301-101301
Closed Access | Times Cited: 1
Prevalencia y factores de riesgo en inmunodeprimidos asociados a infección por covid-19
Javier Martín Reyes-Baque, Bryan Steeven Bazurto-Acuña, Allyson Melissa García- Soledispa
MQRInvestigar (2024) Vol. 8, Iss. 3, pp. 2139-2157
Open Access | Times Cited: 1
Persistent COVID-19 Infection in an Immunocompromised Host: A Case Report
Rashmita Das, Rajesh Karyakarte, Suvarna Joshi, et al.
Cureus (2024)
Open Access | Times Cited: 1
Resilience and Beyond the Acute Phase Challenges: Case Series on Prolonged COVID-19 Infection in Immunocompromised Individuals
Kridsanai Gulapa, Dararat Eksombatchai, Tananchai Petnak, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 4727-4732
Open Access | Times Cited: 1
Case 40-2023: A 70-Year-Old Woman with Cough and Shortness of Breath
Rajesh T. Gandhi, Alison Castle, Túlio de Oliveira, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 26, pp. 2468-2476
Open Access | Times Cited: 3
Perspectives and Challenges of COVID-19 with Obesity-Related Cancers
Μaria Dalamaga, Narjes Nasiri‐Ansari, Nikolaos Spyrou
Cancers (2023) Vol. 15, Iss. 6, pp. 1771-1771
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top